Lv11
48 积分 2024-08-19 加入
Disposition and Absolute Bioavailability of Orally Administered Orforglipron in Healthy Participants
2小时前
已完结
Evaluating Scale-Up Rules of a High-Shear Wet Granulation Process
20天前
已完结
FDA approved PFS-based autoinjectors: evolution, market trends, and development challenges
22天前
已完结
Strategies for Accelerated Drug Development: An Industry Perspective Based on an IQ Consortium Survey of CMC Considerations
1个月前
已完结
Characterization of adsorption behavior by solid dosage form excipients in formulation development
2个月前
已完结
Orforglipron (LY3502970), a novel, oral non‐peptide glucagon‐like peptide‐1 receptor agonist: A Phase 1b, multicentre, blinded, placebo‐controlled, randomized, multiple‐ascending‐dose study in people with type 2 diabetes
2个月前
已完结
Impurity Qualification Thresholds: An IQ Survey on Emerging Industry Experience with Health Authority Feedback
2个月前
已完结
Solid dispersion technology as a formulation strategy for the fabrication of modified release dosage forms: A comprehensive review
6个月前
已完结
皖公网安备34019202002308
